There is enormous need for well-trained providers who are educated in treating opioid use disorder.
The FDA and the Drug Enforcement Administration (DEA) have issued joint warning letters to several website operators that have been illegally selling opioid medications online.
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
Receipt of prescription opioids is associated with an increased risk for death and hospitalization, especially in patients with lower estimated glomerular filtration rates.
Fentanyl and fentanyl analogues may cause rapid death through airway compromise and severe muscle rigidity.
With a federal trial pending, the pharmaceutical giant Johnson & Johnson agreed Wednesday to pay two Ohio counties more than $20 million for its role in the ongoing opioid crisis.
Medication-assisted treatment initiation for opioid use disorder was defined as a prescription of injectable naltrexone or buprenorphine which was recorded in an electronic health record.
The U.S. Preventive Services Task Force (USPSTF) finds that the current evidence is insufficient to recommend primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults.
Discontinuing chronic opioid therapy for pain may not reduce mortality risk, and may be associated with an increased risk for overdose death.
Eight candidate touchpoints are associated with increased risk of fatal opioid overdose.